Abcellera director Michael R Hayden reports purchase of common shares worth $481,234.19

Reuters2026/08/14 15:50

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

AbCellera Biologics director Hayden Michael R Hayden reported an indirect purchase of 46,387 common shares at USD 10.37.
Indirect holdings through Genworks 2 Consulting rose to 1,319,784 common shares.
A separate indirect position of 118,245 common shares was reported as held by the director’s spouse.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abcellera Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-057007), on August 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Abcellera director Michael R Hayden reports purchase of common shares worth $481,234.19

You may also like

Crypto prices